Skip to main content
Log in

Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

In rats acute treatment with 5-HT uptake inhibitors antagonize p-chloro-amphetamine (PCA)-induced hypermotility and 5-HT depletion from brain. To compare the acute and chronic effect on neuronal 5-HT uptake these two effects of PCA were studied after 4 weeks feeding with diets containing the three 5-HT uptake inhibitors femoxetine, paroxetine, and chlorimipramine. Prolonged treatment with 5-HT uptake inhibitors reduce blood 5-HT due to blocked 5-HT uptake into platelets. Blood 5-HT and plasma concentrations of the 5-HT uptake inhibitors were determined.

Femoxetine and paroxetine antagonized both effects of PCA and depleted blood 5-HT at plasma concentrations equivalent to those of patients treated with these substances. The results strongly indicate preservation of inhibited 5-HT uptake into neurons and platelets during prolonged treatment of rats with femoxetine and paroxetine.

The plasma concentrations of chlorimipramine at the highest dose were lower than those of chlorimipramine treated patients, but the concentrations of desmethylchlorimipramine (DCIP) were higher. Inhibition of PCA-induced hypermotility and partial blood 5-HT depletion was obtained at these relatively low plasma levels of the substance itself, but the effect of PCA on brain 5-HT was not changed. In rats, it appears difficult under chronic conditions to keep the plasma concentrations of chlorimipramine high enough to inhibit neuronal 5-HT uptake without simultaneous high toxic concentrations of DCIP which is a weak 5-HT uptake inhibitor. The inhibition of PCA-hypermotility by chlorimipramine is probably caused by the dopamine receptor blockade of this substance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bechgaard, E., Lund, J.: Determination of (+)-(3R), (4S)-3-[(4-methoxyphenoxy)methyl]-1-methyl-4-phenylpiperidine hydrochloride (FG 4963) in biological fluids using competition for adsorption to glass. J. Chromatogr. 133, 147–152 (1977)

    Google Scholar 

  • Buus Lassen, J.: The effect of p-chloroamphetamine on motility in rats after inhibition of monoamine synthesis, storage, uptake and receptor interaction. Psychopharmacologia 34, 243–254 (1974)

    Google Scholar 

  • Buus Lassen, J.: Potentiation of nialamide-induced hypermobility and depletion of blood 5-HT in mice by the new selective 5-HT inhibitor paroxetine. Abstracts, 11th CINP Congress, Vienna 1978

  • Buus Lassen, J., Lund, J., Bechgaard, E., Søndergaard, I.: Inhibition of 5-HT uptake into neurons and platelets in mice treated chronically with chlorimipramine and femoxetine. Psychopharmacology 64, 149–153 (1979)

    Google Scholar 

  • Buus Lassen, J., Petersen, E., Kjellberg, B., Olsson, S. O.: Comparative studies of a new 5-HT-uptake inhibitor and some tricyclic thymoleptics. Eur. J. Pharmacol. 32, 108–115 (1975a)

    Google Scholar 

  • Buus Lassen, J., Squires, R. F.: Potentiation of nialamide-induced hypermotility in mice by lithium and the 5-HT uptake inhibitors chlorimipramine and FG 4963. Neuropharmacology 15, 665–668 (1976)

    Google Scholar 

  • Buus Lassen, J., Squires, R. F., Christensen, J. A., Molander, L.: Neurochemical and pharmacological studies on a new 5-HT-uptake inhibitor, FG 4963, with potential antidepressant properties. Psychopharmacologia 42, 21–26 (1975b)

    Google Scholar 

  • Delini-Stula, A., Vassout, A.: Modulation of dopamine-mediated behavioural responses by antidepressants: Effects of single and repeated treatment. Eur. J. Pharmacol. 58, 443–451 (1979)

    Google Scholar 

  • Della Corte, L., broadhurst, A. D., Sgaragli, G. P., Filippini, S., Heeley, A. F., James, H. D., Faravelli, C., Pazzagli, A.: Clinical response and tricyclic plasma levels during treatment with clomipramine. Br. J. Psychiatry 134, 390–400 (1979)

    Google Scholar 

  • Eggum, B. O., Møllegaard Hansen, K. E.: Nord. Veterinærmed. 19, 592–597 (1976) (Norwegian)

    Google Scholar 

  • Fuller, R. W., Perry, K. W., Molloy, B. B.: Effect of 3-(p-trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine. J. Pharmacol. Exp. Ther. 193, 796–803 (1975)

    Google Scholar 

  • Heltberg, J., Larsen, J. K., Kirk, L., Bjørum, N.: Nord. Psykiatr. Tidsskr. 29, 485–486 (1975) (Norwegian)

    Google Scholar 

  • Hyttel, J.: Effect of a specific 5-HT uptake inhibitor, citalopram (lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro. Psychopharmacology 60, 13–18 (1978)

    Google Scholar 

  • Jones, R. B., Luscombe, D. K.: Plasma levels of chlomipramine and its N-desmethylmetabolite following oral administration of clomipramine in man. Br J. Pharmacol. 57, 430 (1976)

    Google Scholar 

  • Jonsson, J., Lewander, T.: A method for the simultaneous determination of 5-hydroxy-3-indole-acetic acid (5-HIAA) and 5-hydroxy-tryptamine (5-HT) in brain tissue and cerebrospinal fluid. Acta Physiol. Scand. 78, 43–51 (1970)

    Google Scholar 

  • Keller, H. H., Burkard, W. P., Da Prade, M.: Dopamine receptor blockade in rat brain after acute and subchronic treatment with tricyclic antidepressant. Abstracts, Intern. Symposium, Long-term effects of neuroleptics, Monte-Carlo, March 19–22 (1979)

  • Nagy, A.: Blood and brain concentrations of imipramine, clomipramine and their monomethylated metabolites after oral and intramuscular administration in rats. J. Pharm. Pharmacol. 29, 104–107 (1977)

    Google Scholar 

  • Nagy, A., Johansson, R.: The demethylation of imipramine and clomipramine as apparent from their plasma kinetics. Psychopharmacology 54, 125–131 (1977)

    Google Scholar 

  • Nagy, A., Treiber, L.: Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin-layer chromatograms. J. Pharm. Pharmacol. 25, 599–603 (1973)

    Google Scholar 

  • Petersen, E. N., Bechgaard, E., Sortwell, R. J., Wetterberg, L.: Potent depletion of 5-HT from monkey whole blood by a new 5-HT uptake inhibitor, paroxetine (FG 7051). Eur. J. Pharmacol. 52, 115–119 (1978)

    Google Scholar 

  • Ross, S. B., Jansa, S., Wetterberg, L., Fyrö, B., Hellner, B.: Decreased blood level of 5-hydroxytryptamine by inhibitors of the membranal 5-hydroxytryptamine uptake. Life Sci 19, 205–210 (1976)

    Google Scholar 

  • Squires, R.: Antagonism of p-chloroamphetamine (PCA) induced depletion of 5-HT from rat brain by some thymoleptics and other psychotropic drugs. Acta Pharmacol. Toxicol. [Suppl.] (Kbh.) 31, 35 (1972)

    Google Scholar 

  • Squires, R. F.: Evidence that 5-methoxy-N,N-dimethyl tryptamine is a specific substrate for MAO-A in the rat: implications for the indoleamine dependent behavioural syndrome. J. Neurochem. 24, 47–50 (1975)

    Google Scholar 

  • Sugrue, M. F., Goodlet, I., Mireyless, S. E.: On the selective inhibition of serotonin uptake in vivo by ORG 6582. Eur. J. Pharmacol 40, 121–130 (1976)

    Google Scholar 

  • Svensson, T. H., Thieme, G.: An investigation of a new instrument to measure motor activity of small animals. Psychopharmacologia 14, 157–163 (1969)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lassen, J.B., Lund, J. & Søndergaard, I. Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine. Psychopharmacology 68, 229–233 (1980). https://doi.org/10.1007/BF00428108

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00428108

Key words

Navigation